Giant Biogene Holding Co., Ltd. (HKG: 2367)

Market Cap	58.88B
Revenue (ttm)	4.79B
Net Income (ttm)	1.90B
Shares Out	1.02B
EPS (ttm)	1.93
PE Ratio	29.97
Forward PE	24.05
Dividend	0.48 (0.83%)
Ex-Dividend Date	n/a

Volume	1,199,640
Average Volume	2,734,622
Open	54.50
Previous Close	54.40
Day's Range	54.00 - 57.90
52-Week Range	28.75 - 58.00
Beta	0.72
RSI	72.35
Earnings Date	Mar 26, 2025

About Giant Biogene Holding

Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People’s Republic of China. It also manufactures rare ginsenosides technology-based functional foods; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional foods primarily under the Comfy, Collgene, Keyu, and SKIGIN brands. Giant Biogene Holding Co., Ltd. was founded in 2000 and is headquartered in Xi’...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2000
• Employees: 1,164
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2367

Financial Performance

In 2023, Giant Biogene Holding's revenue was 3.52 billion, an increase of 49.05% compared to the previous year's 2.36 billion. Earnings were 1.45 billion, an increase of 108.59%.

Financial numbers in CNY